Shortages: Ketamine

Ketamine is an anesthetic drug that has been shown to be effective in treating some forms of severe mental illness, especially severe depression and post-traumatic stress disorder. It’s commonly used when other forms of treatment have been unsuccessful and exhausted. Unfortunately, this increased demand coupled with the fact that using ketamine to treat severe depression is an “off-label” use of the drug, ketamine has now joined ozempic and many other vital medications on the FDA’s Drug Shortage List. This is particularly dangerous because when a suicidal or severely depressed patient has been stabilized using ketamine, they need regular doses of the drug — or maintenance doses — to remain stable.

Like Semaglutide, the FDA-approved active ingredient in ozempic, various strengths of ketamine, which is given intravenously, can be compounded as long as ketamine remains on the Drug Shortage List, throwing severely depressed patients who depend on the drug a literal lifeline.

More like this...

Image

Hear their stories. Protect their own words. Protect their access to compounded medicines.

On this page, we can only touch on the data that demonstrates the importance of compounded medicines to the lives of millions of people in this country. While the decision to take this vital therapy from patients and physicians might be profitable for big pharmaceutical companies, it will be disastrous for the millions of patients that those same pharmaceutical companies cannot serve!

We encourage the appropriate committees in both the House and Senate to hold hearings on this critical issue.

Explore our interactive map that demonstrates the importance of compounded medicines to patients all across the country. Filter these first-hand accounts by state to see just how vital compounded medicines are.

No. of testimonials